AAFA Statement in Response to AstraZeneca Asthma Inhaler Cost Announcement Washington, DC, March 18, 2024 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) welcomes efforts to make asthma medicines more affordable and accessible. AAFA continues to...

AAFA Statement on Asthma Inhaler Price Caps Washington, DC, March 08, 2024 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) is leading advocacy efforts to change the drug pricing ecosystem and to make medicines more...